CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on: April 12,2024 15

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on:April 12,2024 15

Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib

by Associação Advanced Breast Cancer Global AllianceCredit: Unsplash/CC0 Public DomainPatients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer

Updated on: April 18,2024 0

Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib

by Associação Advanced Breast Cancer Global AllianceCredit: Unsplash/CC0 Public DomainPatients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer

Updated on:April 18,2024 0

Study refines understanding of T cells' action in HIV immune response

by Los Alamos National LaboratoryThe effect of M-T807R1 administration and RAL monotherapy on blood CD8+T cell dynamics. The effects of M-T807R1 on the dynamics of CD8 cells in individual m

Updated on: July 04,2024 5

Study refines understanding of T cells' action in HIV immune response

by Los Alamos National LaboratoryThe effect of M-T807R1 administration and RAL monotherapy on blood CD8+T cell dynamics. The effects of M-T807R1 on the dynamics of CD8 cells in individual m

Updated on:July 04,2024 5

Cancer screening rates decline when patients see doctors later in day

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCompared to patients who see their primary care doctor earlier in the day, cancer screening rates decline

Updated on: March 08,2024 11

Cancer screening rates decline when patients see doctors later in day

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCompared to patients who see their primary care doctor earlier in the day, cancer screening rates decline

Updated on:March 08,2024 11

Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

by Elana GotkineSurvivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more

Updated on: January 23,2024 11

Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

by Elana GotkineSurvivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more

Updated on:January 23,2024 11

Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBlack women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women

Updated on: January 13,2024 17

Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBlack women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women

Updated on:January 13,2024 17

Maximizing the potential of 3D-patient tumor avatars for next-generation precision oncology

by Terasaki Institute for Biomedical Innovation3D Patient Tumor Avatars (3D-PTAs) are part of a proposed integrative platform to provide optimal treatment selections for cancer patients. Such a platfo

Updated on: January 21,2024 19

Maximizing the potential of 3D-patient tumor avatars for next-generation precision oncology

by Terasaki Institute for Biomedical Innovation3D Patient Tumor Avatars (3D-PTAs) are part of a proposed integrative platform to provide optimal treatment selections for cancer patients. Such a platfo

Updated on:January 21,2024 19

New imaging technique improves accuracy of diagnosis for most common skin cancer

by European Academy of Dermatology and VenereologyCredit: Unsplash/CC0 Public DomainA novel imaging technique significantly improves the accuracy of the diagnosis of basal cell carcinoma (BCC)—the mos

Updated on: January 11,2024 10

New imaging technique improves accuracy of diagnosis for most common skin cancer

by European Academy of Dermatology and VenereologyCredit: Unsplash/CC0 Public DomainA novel imaging technique significantly improves the accuracy of the diagnosis of basal cell carcinoma (BCC)—the mos

Updated on:January 11,2024 10

Study finds association between TB infection and increased risk of various cancers

by European Society of Clinical Microbiology and Infectious DiseasesCredit: Pixabay/CC0 Public DomainA population-wide observational study to be presented at this year'sEuropean Congress of

Updated on: April 06,2024 0

Study finds association between TB infection and increased risk of various cancers

by European Society of Clinical Microbiology and Infectious DiseasesCredit: Pixabay/CC0 Public DomainA population-wide observational study to be presented at this year'sEuropean Congress of

Updated on:April 06,2024 0

Researchers find timing, dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence

by Bendta Schroeder,Massachusetts Institute of TechnologyNormal cells (blue) entering senescence (green to yellow) or apoptosis (purple to red) after treatment with chemotherapy. Credit: Bendta

Updated on: February 18,2024 17

Researchers find timing, dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence

by Bendta Schroeder,Massachusetts Institute of TechnologyNormal cells (blue) entering senescence (green to yellow) or apoptosis (purple to red) after treatment with chemotherapy. Credit: Bendta

Updated on:February 18,2024 17

Research points the way toward an exhaled-breath test for lung cancer

by Hackensack Meridian HealthOlivier Loudig, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI). Credit: Hackensack Meridian HealthThe foundational science to develop an exhal

Updated on: August 03,2024 0

Research points the way toward an exhaled-breath test for lung cancer

by Hackensack Meridian HealthOlivier Loudig, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI). Credit: Hackensack Meridian HealthThe foundational science to develop an exhal

Updated on:August 03,2024 0

Redefining colorectal cancer subtypes

by The City University of New YorkCredit: The City University of New YorkThere is a long-standing belief that colorectal cancer (CRC), which causes some 50,000 deaths in the United States each ye

Updated on: April 07,2024 11

Redefining colorectal cancer subtypes

by The City University of New YorkCredit: The City University of New YorkThere is a long-standing belief that colorectal cancer (CRC), which causes some 50,000 deaths in the United States each ye

Updated on:April 07,2024 11